JAMA Dermatology : Topical Rapamycin in Patients With Facial Angiofibromas

Interview with Mary Kay Koenig, MD, author of Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial

Source: JAMA Specialty Journals Author Interviews - May 23, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts